Skip links
Companies
› United States › ACTINIUM PHARMACEUTICALS, INC.
ACTINIUM PHARMACEUTICALS, INC. logo

ACTINIUM PHARMACEUTICALS, INC.

Private limited company (Ltd.) Active

in

Registration No.
4297191
Incorporation Date
2012-09-18
Company Type
Private limited company (Ltd.)
Address
New York, United States
Website
www.actiniumpharmaceuticals.com/
Source: New York Department of State — Division of Corporations

ACTINIUM PHARMACEUTICALS, INC. is a Private limited company (Ltd.) registered in United States under 4297191, and its current status with New York Department of State — Division of Corporations is active. The company was incorporated on 18 September 2012 and lists its registered address as New York, United States. 1 shareholder is on record for ACTINIUM PHARMACEUTICALS, INC., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from New York Department of State — Division of Corporations and was last updated on 18 September 2026.

Data Provenance
This record is sourced directly from official government registries, including New York Department of State — Division of Corporations.

View data sources →

We don’t stop at registry data.
Every company record is enriched with additional intelligence:
  • Company fundamentals
  • Corporate linkage & group structures
  • Digitized company financials
  • Firmographics — websites, social profiles, revenue and employee estimates

View full data dictionary →

Shareholders

1

Shareholders of ACTINIUM PHARMACEUTICALS, INC.

One shareholder is currently on record for ACTINIUM PHARMACEUTICALS, INC., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing. The largest of these is Vanguard Group Inc, holding 24% — the largest recorded stake. Because the shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.

Shareholder Type Holding Source Document
Vanguard Group Inc 24% New York Department of State — Division of Corporations

View all shareholders & beneficial ownership
Full cap table, ownership percentages, and ultimate beneficial owners resolved down to the natural person.

View all shareholders →

Officers

15

Directors and officers of ACTINIUM PHARMACEUTICALS, INC.

The Chairman & Ceo of ACTINIUM PHARMACEUTICALS, INC. currently on record is Sandesh C. Seth M.b.a., M.s.; 15 officers are currently on record for ACTINIUM PHARMACEUTICALS, INC., filed with New York Department of State — Division of Corporations. Management authority at ACTINIUM PHARMACEUTICALS, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control. The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.

SC
Sandesh C. Seth M.b.a., M.s. ACTIVE

Residence
🇺🇸 United States
Occupation
Chairman & Ceo

BC
Bernie Cunningham P.m.p., Ph.d. ACTIVE

Residence
🇺🇸 United States
Occupation
Executive Director Of Clinical Supply Chain & Logistics And Cmc Project Management

JC
J. C. Simeon ACTIVE

Residence
🇺🇸 United States
Occupation
Executive Director Of Quality Assurance

QL
Qing Liang ACTIVE

Appointed
2019-01-01
Residence
🇺🇸 United States
Occupation
Vp & Head Of Radiation Sciences

EH
Elaina Haeuber ACTIVE

Appointed
2022-07-01
Residence
🇺🇸 United States
Occupation
Vp & Head Of Clinical Operations

CY
Caroline Yarbrough ACTIVE

Appointed
2022-10-01
Residence
🇺🇸 United States
Occupation
Chief Commercial Officer

PD
Paul Diamond Esq., Ph.d. ACTIVE

Residence
🇺🇸 United States
Occupation
Vice President Of Patent & Legal Counsel

LM
Lynn M. Bodarky M.b.a. ACTIVE

Residence
🇺🇸 United States
Occupation
Chief Business Officer

PA
PHARMACEUTI ACTINIUM ACTIVE

Residence
🇺🇸 United States
Occupation
Processor

MV
Madhuri Vusirikala M.d. ACTIVE

Residence
🇺🇸 United States
Occupation
Vice President Of Clinical Development Bmt & Cellular Therapy

JH
Jenny Hsieh ACTIVE

Residence
🇺🇸 United States
Occupation
Chief Strategy Officer

DG
David Gould ACTIVE

Residence
🇺🇸 United States
Occupation
Senior Vice President Of Corporate Development & Corporate Affairs

AD
Avinash Desai M.d. ACTIVE

Residence
🇺🇸 United States
Occupation
Chief Medical Officer

SL
SUNITHA LAKSHMINARAYANAN ACTIVE

Residence
🇺🇸 United States
Occupation
Senior Vp, Head Of Cmc & Product Development

SO
Steven O'loughlin Bs ACTIVE

Residence
🇺🇸 United States
Occupation
Cfo & Corporate Secretary

View all officers & directors
Complete appointment history, representation authority, and officer-level filings across jurisdictions.

View all officers →

Group Structure

Group structure of ACTINIUM PHARMACEUTICALS, INC.

ACTINIUM PHARMACEUTICALS, INC. has no recorded parent company — it sits at the top of its own group structure, with 1 subsidiary recorded beneath it across 2 jurisdictions. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.

  • ACTINIUM PHARMACEUTICALS AUSTRALIA PTY LTD (Australia)

Data availability

Those 1 subsidiary spans United States, Australia jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.

Ultimate HQ
ACTINIUM PHARMACEUTICALS, INC.
United States
ACTINIUM PHARMACEUTICALS AUSTRALIA PTY LTD
AustraliaAU 689055392

Explore the full group structure
Map the complete corporate hierarchy: parent companies, subsidiaries, and cross-border ownership chains.

View full group structure →

Need the full UBO picture on ACTINIUM PHARMACEUTICALS, INC.?

Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.

Frequently Asked Questions

Who owns ACTINIUM PHARMACEUTICALS, INC.?

One shareholder is currently on record for ACTINIUM PHARMACEUTICALS, INC., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing. The largest of these is Vanguard Group Inc, holding 24% — the largest recorded stake. Because the shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.

Who is ACTINIUM PHARMACEUTICALS, INC.'s UBO (Ultimate Beneficial Owner)?

Every shareholder recorded for ACTINIUM PHARMACEUTICALS, INC. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.

How many shareholders does ACTINIUM PHARMACEUTICALS, INC. have on record?

1 shareholder is shown on record for ACTINIUM PHARMACEUTICALS, INC..

What is ACTINIUM PHARMACEUTICALS, INC.'s company registration number?

ACTINIUM PHARMACEUTICALS, INC.'s registration number is 4297191, filed with New York Department of State — Division of Corporations in United States. Its current status on the register is active.

Is ACTINIUM PHARMACEUTICALS, INC. still an active company?

ACTINIUM PHARMACEUTICALS, INC.'s status on New York Department of State — Division of Corporations is listed as active.

When was ACTINIUM PHARMACEUTICALS, INC. incorporated?

ACTINIUM PHARMACEUTICALS, INC. was incorporated on 18 September 2012, according to New York Department of State — Division of Corporations.

What is ACTINIUM PHARMACEUTICALS, INC.'s registered address?

The registered address on file for ACTINIUM PHARMACEUTICALS, INC. is New York, United States.

What legal structure is ACTINIUM PHARMACEUTICALS, INC. registered as?

ACTINIUM PHARMACEUTICALS, INC. is registered as a Private limited company (Ltd.) in United States.

Who are the officers/directors of ACTINIUM PHARMACEUTICALS, INC.?

The Chairman & Ceo of ACTINIUM PHARMACEUTICALS, INC. currently on record is Sandesh C. Seth M.b.a., M.s.; 15 officers are currently on record for ACTINIUM PHARMACEUTICALS, INC., filed with New York Department of State — Division of Corporations. Management authority at ACTINIUM PHARMACEUTICALS, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.

Does ACTINIUM PHARMACEUTICALS, INC. have a parent company or subsidiaries?

ACTINIUM PHARMACEUTICALS, INC. has no recorded parent company — it sits at the top of its own group structure, with 1 subsidiary recorded beneath it across 2 jurisdictions. Those 1 subsidiary spans United States, Australia jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.

Can Zavia monitor changes to ACTINIUM PHARMACEUTICALS, INC.'s ownership over time?

This profile reflects a point-in-time snapshot from New York Department of State — Division of Corporations. Zavia's monitoring API can track changes to ACTINIUM PHARMACEUTICALS, INC.'s registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.

Can I access ACTINIUM PHARMACEUTICALS, INC.'s data through an API?

Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including United States, so records like ACTINIUM PHARMACEUTICALS, INC.'s registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.

Where does this company information come from, and how current is it?

This record is sourced directly from New York Department of State — Division of Corporations and was last synced on 18 September 2026.

This website uses cookies to improve your web experience.